1 - 25 of 54 results for author:"Trapman J." in Literature citations
Results Customize
› Repeat search in UniProtKB (19)
| Stepwise androgen receptor dimerization. van Royen M.E., van Cappellen W.A., de Vos C., Houtsmuller A.B., Trapman J. J. Cell. Sci. 125:1970-1979(2012) · Mapped (11) |
| Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation. Gasi D., van der Korput H.A., Douben H.C., de Klein A., de Ridder C.M., van Weerden W.M., Trapman J. PLoS ONE 6:e16332-e16332(2011) · Mapped (7) |
| E17K substitution in AKT1 in prostate cancer. Boormans J.L., Korsten H., Ziel-van der Made A.C., van Leenders G.J., Verhagen P.C., Trapman J. Br. J. Cancer 102:1491-1494(2010) · Mapped (21) |
| Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H. van de Wijngaart D.J., Molier M., Lusher S.J., Hersmus R., Jenster G., Trapman J., Dubbink H.J. J. Biol. Chem. 285:5097-5105(2010) · Mapped (11) |
| Functional analysis of novel androgen receptor mutations in a unique cohort of Indonesian patients with a disorder of sex development. Elfferich P., Juniarto A.Z., Dubbink H.J., van Royen M.E., Molier M., Hoogerbrugge J., Houtsmuller A.B., Trapman J., Santosa A., de Jong F.H. et al. Sex Dev 3:237-244(2009) · Mapped (11) |
| PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators. van Duijn P.W., Ziel-van der Made A.C., van der Korput J.A., Trapman J. Prostate 70:135-146(2010) · Mapped (3) |
| Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression. van de Wijngaart D.J., Dubbink H.J., Molier M., de Vos C., Trapman J., Jenster G. Mol. Endocrinol. 23:1776-1786(2009) · Mapped (6) |
| Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. Korsten H., Ziel-van der Made A., Ma X., van der Kwast T., Trapman J. PLoS ONE 4:e5662-e5662(2009) · Mapped (5) |
| Conditional Pten knock-out mice: a model for metastatic phaeochromocytoma. Korpershoek E., Loonen A.J., Corvers S., van Nederveen F.H., Jonkers J., Ma X., Ziel-van der Made A., Korsten H., Trapman J., Dinjens W.N. et al. J. Pathol. 217:597-604(2009) · Mapped (5) |
| An activating mutation in AKT1 in human prostate cancer. Boormans J.L., Hermans K.G., van Leenders G.J., Trapman J., Verhagen P.C. Int. J. Cancer 123:2725-2726(2008) · Mapped (5) |
| A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation. Wong H.Y., Hoogerbrugge J.W., Pang K.L., van Leeuwen M., van Royen M.E., Molier M., Berrevoets C.A., Dooijes D., Dubbink H.J., van de Wijngaart D.J. et al. Mol. Cell. Endocrinol. 292:69-78(2008) · Mapped (15) |
| Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. Hermans K.G., Bressers A.A., van der Korput H.A., Dits N.F., Jenster G., Trapman J. Cancer Res. 68:3094-3098(2008) · Mapped (5) |
| Evolution of the androgen receptor pathway during progression of prostate cancer. Hendriksen P.J., Dits N.F., Kokame K., Veldhoven A., van Weerden W.M., Bangma C.H., Trapman J., Jenster G. Cancer Res. 66:5012-5020(2006) · Mapped (2) |
| Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. van de Wijngaart D.J., van Royen M.E., Hersmus R., Pike A.C., Houtsmuller A.B., Jenster G., Trapman J., Dubbink H.J. J. Biol. Chem. 281:19407-19416(2006) · Mapped (11) |
| Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Dubbink H.J., Hersmus R., Pike A.C., Molier M., Brinkmann A.O., Jenster G., Trapman J. Mol. Endocrinol. 20:1742-1755(2006) · Mapped (11) |
| PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells. van Duijn P.W., Trapman J. Prostate 66:749-760(2006) · Mapped (2) |
| Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Ma X., Ziel-van der Made A.C., Autar B., van der Korput H.A., Vermeij M., van Duijn P., Cleutjens K.B., de Krijger R., Krimpenfort P., Berns A. et al. Cancer Res. 65:5730-5739(2005) · Mapped (5) |
| Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment. Marques R.B., Erkens-Schulze S., de Ridder C.M., Hermans K.G., Waltering K., Visakorpi T., Trapman J., Romijn J.C., van Weerden W.M., Jenster G. Int. J. Cancer 117:221-229(2005) · Mapped (11) |
| A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron. Steketee K., Ziel-van der Made A.C., van der Korput H.A., Houtsmuller A.B., Trapman J. J. Mol. Endocrinol. 33:477-491(2004) · UniProtKB (1) · Mapped (1) |
| The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. Hagenbeek T.J., Naspetti M., Malergue F., Garcon F., Nunes J.A., Cleutjens K.B., Trapman J., Krimpenfort P., Spits H. J. Exp. Med. 200:883-894(2004) · Mapped (16) |
| Phosphorylation of androgen receptor isoforms. Wong H.Y., Burghoorn J.A., Van Leeuwen M., De Ruiter P.E., Schippers E., Blok L.J., Li K.W., Dekker H.L., De Jong L., Trapman J. et al. Biochem. J. 383:267-276(2004) · Mapped (11) |
| The androgen receptor ligand-binding domain stabilizes DNA binding in living cells. Farla P., Hersmus R., Geverts B., Mari P.O., Nigg A.L., Dubbink H.J., Trapman J., Houtsmuller A.B. J. Struct. Biol. 147:50-61(2004) · Mapped (11) |
| Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR). Berrevoets C.A., Umar A., Trapman J., Brinkmann A.O. Biochem. J. 379:731-738(2004) · Mapped (12) |
| PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Marino S., Krimpenfort P., Leung C., van der Korput H.A., Trapman J., Camenisch I., Berns A., Brandner S. Development 129:3513-3522(2002) · Mapped (28) |
| Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene. Mononen N., Syrjakoski K., Matikainen M., Tammela T.L., Schleutker J., Kallioniemi O.P., Trapman J., Koivisto P.A. Cancer Res. 60:6479-6481(2000) · Mapped (11) |